Business - Briefly   

Strides Arcolab forms JV with Turkish firm

MUMBAI: Strides Arcolab has informed the stock exchange that the company and Abdi Ibrahim, Turkey's largest pharmaceutical company, has signed a 50:50 joint venture agreement to introduce a range of specialty pharmaceutical products developed by the company for the Turkish and neighbouring markets. The new company will be called Abdi Strides and will leverage the product pipeline and manufacturing capabilities of the company and the sales and marketing leadership of Abdi Ibrahim in Turkey.

Printer friendly page  
Send this article to Friends by E-Mail

Stories in this Section

Telcordia to make Chennai its hub
G-8 fear U.S. deficit may derail global growth
Arcelor says `no' to Mittal's new terms
SAT stays SEBI order for revamp of NSDL
Air-conditioner prices set to go up
MKCL plans stock listing
RBI directive to banks on BIS code
LGEIL plans new unit for washing machines
SEZ Board nod for 17 companies
Rupee ends higher
Sensex nosedives 334 points
Design consultants appointed for work on container terminal
KSIDC helps machinist to design outboard engine for fishermen
BSE/NSE NOTES
Exchange rates
Bullion rates
Big five vie for BSNL's GSM tender
Industrial growth perks up in April
Stanchart raises home loan rates
Deccan, Unity Infra slip below IPO price
Asian Paints to offload stake in Philippines co
Ericsson to sell defence unit to Saab
Dr. Fixit Centre opened in Coimbatore
Apollo Hospitals pays Rs. 4.50 per share
Ciba Specialty JV with Virchow Drugs
Strides Arcolab forms JV with Turkish firm
New Vice-President for TalentPro India
SpiceJet records 92 p.c. passenger load factor
PLM excellence award
Tech Mahindra on recruitment drive
50 p.c. maiden dividend from Royal Orchid
First Flight takes delivery of ATPF aircraft
Initiative to promote monsoon tourism

Copyright © 2006, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu